Clinical Trials

Showing trials with last updates posted in 2025.

NCT05767970 | COMPLETED | NA
2315 participants

Stress Toolbox for Healthcare Providers in Mexico

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-04-04
Completion:
2024-03-31
Conditions
  • Distress, Emotional
  • Burnout, Professional
  • Inflammation
  • Emotion Regulation
Interventions
  • BEHAVIORAL
No Results Yet
NCT05761899 | RECRUITING | PHASE1/PHASE2
3 participants

Safety and Efficacy of PMT Therapy of hPAP

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-06-26
Completion:
2026-09-01
Conditions
  • Hereditary Pulmonary Alveolar Proteinosis
Interventions
  • COMBINATION_PRODUCT
No Results Yet
NCT05745493 | COMPLETED | NA
29 participants

Study 1: Social Engage Coaching R61 Phase

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-06-13
Completion:
2025-09-30
Conditions
  • Social Isolation
  • Loneliness
  • Suicide Ideation
  • Quality of Life
Interventions
  • BEHAVIORAL
No Results Yet
NCT05628948 | RECRUITING
500 participants

Vascular Lab Resource (VLR) Biorepository

Study Type:
OBSERVATIONAL
Last Updated:
2025-12-19
Start Date:
2019-11-14
Completion:
2030-12-31
Conditions
  • Cardiovascular Diseases
  • Metabolic Disease
  • Peripheral Artery Disease
  • Carotid Disease
  • Aneurysmal Disease
  • Venous Disease
  • Thrombosis
  • Lymphedema
  • Lipedema
  • Non-Atherosclerotic Chronic Arterial Occlusive Disease
  • Vasculitis
  • Fibromuscular Dysplasia
  • Arterial Dissection
  • May-Thurner Syndrome
  • Thoracic Outlet Syndrome
  • Vasospasm
No Results Yet
NCT05575700 | COMPLETED | PHASE4
2904 participants

Safety of Ibuprofen After Major Orthopaedic Surgeries

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-04-17
Completion:
2025-08-19
Conditions
  • Pain, Acute
  • Hip Arthropathy
  • Knee Arthropathy
  • Safety Issues
  • Analgesia
  • Analgesic Adverse Reaction
  • Postoperative Pain
  • Postoperative Complications
Interventions
  • DRUG
No Results Yet
NCT05276973 | ACTIVE_NOT_RECRUITING | PHASE1
25 participants

Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-09-08
Completion:
2025-01-30
Conditions
  • Fallopian Tube Endometrioid Adenocarcinoma
  • Fallopian Tube High Grade Serous Adenocarcinoma
  • Ovarian Endometrioid Adenocarcinoma
  • Ovarian High Grade Serous Adenocarcinoma
  • Primary Peritoneal Endometrioid Adenocarcinoma
  • Primary Peritoneal High Grade Serous Adenocarcinoma
  • Stage III Fallopian Tube Cancer AJCC v8
  • Stage III Ovarian Cancer AJCC v8
  • Stage III Primary Peritoneal Cancer AJCC v8
  • Stage IV Fallopian Tube Cancer AJCC v8
  • Stage IV Ovarian Cancer AJCC v8
  • Stage IV Primary Peritoneal Cancer AJCC v8
  • Unresectable Fallopian Tube Endometrioid Adenocarcinoma
  • Unresectable Fallopian Tube High Grade Serous Adenocarcinoma
  • Unresectable Ovarian Endometrioid Adenocarcinoma
  • Unresectable Ovarian High Grade Serous Adenocarcinoma
  • Unresectable Primary Peritoneal Endometrioid Adenocarcinoma
  • Unresectable Primary Peritoneal High Grade Serous Adenocarcinoma
Interventions
  • PROCEDURE
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page